SCHEMBL7005495

SCHEMBL7005495

N[C@@H]1C[C@H]1c1cccc(-c2ccccc2)c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 15/20 0.68
MAOB P27338 9/20 0.68
MAOA P21397 8/20 0.65
CYP2C19 P33261 4/20 0.65
CYP2B6 P20813 3/20 0.65
CYP1A2 P05177 2/20 0.65
CYP2D6 P10635 2/20 0.65
CYP2C9 P11712 2/20 0.65
LMNA P02545 2/20 0.65
TAAR1 Q96RJ0 2/20 0.65
CYP3A4 P08684 1/20 0.65
HTR1A P08908 1/20 0.65
ADRA2A P08913 1/20 0.65
CYP2A6 P11509 1/20 0.65
SLC6A2 P23975 1/20 0.65
HTR2C P28335 1/20 0.65
ADRA1A P35348 1/20 0.65
DRD3 P35462 1/20 0.65
SLC6A3 Q01959 1/20 0.65
KCNH2 Q12809 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7005493 1.00 KDM1A (0.68) KDM1AMAOBMAOACYP2C19CYP2B6
SCHEMBL526553 0.87 KDM1A (0.59) KDM1AMAOBMAOACYP2C19CYP2B6
SCHEMBL527486 0.87 KDM1A (0.59) KDM1AMAOBMAOACYP2C19CYP2B6
Hydrochloric Acid SCHEMBL527650 0.85 KDM1A (0.60) KDM1AMAOBMAOACYP2C19CYP2B6
SCHEMBL529679 0.81 KDM1A (1.00) KDM1AMAOBMAOACYP2C19CYP2B6
SCHEMBL1524462 0.81 KDM1A (1.00) KDM1AMAOBMAOACYP2C19CYP2B6
SCHEMBL1524464 0.81 KDM1A (1.00) KDM1AMAOBMAOACYP2C19CYP2B6
SCHEMBL7003696 0.81 KDM1A (1.00) KDM1AMAOBMAOACYP2C19CYP2B6
SCHEMBL18949350 0.81 KDM1A (1.00) KDM1AMAOBMAOACYP2C19CYP2B6
SCHEMBL6837366 0.81 KDM1A (1.00) KDM1AMAOBMAOACYP2C19CYP2B6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0996621-B1 TRIAZOLO[4,5-d]PYRIMIDINE DERIVATIVES AS ANTI-THROMBOTIC AGENTS ASTRAZENECA AB (SE) 2003-10-01 EP disclosed
US-6251910-B1 1,2,3-triazolo[4,5-d]pyrimidines as P2T receptor antagonists ASTRAZENECA UK LIMITED (GB) 2001-06-26 US disclosed